2.3060
-0.1560
(-6.34%)
As of 5:00:07 PM GMT+2. Market Open.
Loading Chart for 940.BE
- Previous Close
2.4620 - Open
2.3560 - Bid 2.2940 x --
- Ask 2.3140 x --
- Day's Range
2.3060 - 2.3560 - 52 Week Range
2.3060 - 4.5220 - Volume
0 - Avg. Volume
39 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Mar 3, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 940.BE
View MorePerformance Overview: 940.BE
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .
YTD Return
940.BE
17.70%
CAC 40 (^FCHI)
7.01%
1-Year Return
940.BE
22.04%
CAC 40 (^FCHI)
14.74%
3-Year Return
940.BE
81.39%
CAC 40 (^FCHI)
4.81%
5-Year Return
940.BE
81.39%
CAC 40 (^FCHI)
52.28%
Compare To: 940.BE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
5.47
+1.30%
Mkt Cap EUR 313.322M
Industry Drug Manufacturers—Specialty & Generic
47.40
-1.86%
Mkt Cap EUR 455.194M
Industry Drug Manufacturers—Specialty & Generic
8.77
-5.44%
Mkt Cap EUR 1.997B
Industry Drug Manufacturers—Specialty & Generic
3.1400
-3.09%
Mkt Cap EUR 3.677B
Industry Drug Manufacturers—Specialty & Generic
Statistics: 940.BE
View MoreValuation Measures
As of 4/8/2025
Market Cap
233.50M
Enterprise Value
229.60M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.25
Price/Book (mrq)
0.24
Enterprise Value/Revenue
0.25
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--